A citation-based method for searching scientific literature

George E Woody, Sabrina A Poole, Geetha Subramaniam, Karen Dugosh, Michael Bogenschutz, Patrick Abbott, Ashwin Patkar, Mark Publicker, Karen McCain, Jennifer Sharpe Potter, Robert Forman, Victoria Vetter, Laura McNicholas, Jack Blaine, Kevin G Lynch, Paul Fudala. JAMA 2008
Times Cited: 243







List of co-cited articles
701 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
Lisa A Marsch, Warren K Bickel, Gary J Badger, Marne E Stothart, Kimberly J Quesnel, Catherine Stanger, John Brooklyn. Arch Gen Psychiatry 2005
117
36


A randomized controlled trial of buprenorphine taper duration among opioid-dependent adolescents and young adults.
Lisa A Marsch, Sarah K Moore, Jacob T Borodovsky, Ramon Solhkhah, Gary J Badger, Shelby Semino, Kate Jarrett, Kathleen DiGangi Condon, Kate Rossettie, Phillip Vincent,[...]. Addiction 2016
48
68

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Joshua D Lee, Edward V Nunes, Patricia Novo, Ken Bachrach, Genie L Bailey, Snehal Bhatt, Sarah Farkas, Marc Fishman, Phoebe Gauthier, Candace C Hodgkins,[...]. Lancet 2018
341
24

Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trial.
Roger D Weiss, Jennifer Sharpe Potter, David A Fiellin, Marilyn Byrne, Hilary S Connery, William Dickinson, John Gardin, Margaret L Griffin, Marc N Gourevitch, Deborah L Haller,[...]. Arch Gen Psychiatry 2011
339
23

Trends in Receipt of Buprenorphine and Naltrexone for Opioid Use Disorder Among Adolescents and Young Adults, 2001-2014.
Scott E Hadland, J Frank Wharam, Mark A Schuster, Fang Zhang, Jeffrey H Samet, Marc R Larochelle. JAMA Pediatr 2017
144
23

Receipt of Timely Addiction Treatment and Association of Early Medication Treatment With Retention in Care Among Youths With Opioid Use Disorder.
Scott E Hadland, Sarah M Bagley, Jonathan Rodean, Michael Silverstein, Sharon Levy, Marc R Larochelle, Jeffrey H Samet, Bonnie T Zima. JAMA Pediatr 2018
91
24

Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility.
Marc J Fishman, Erin L Winstanley, Erin Curran, Shannon Garrett, Geetha Subramaniam. Addiction 2010
54
37


Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Richard P Mattick, Courtney Breen, Jo Kimber, Marina Davoli. Cochrane Database Syst Rev 2014
864
17

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.
Luis Sordo, Gregorio Barrio, Maria J Bravo, B Iciar Indave, Louisa Degenhardt, Lucas Wiessing, Marica Ferri, Roberto Pastor-Barriuso. BMJ 2017
809
16

Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence.
Richard P Mattick, Courtney Breen, Jo Kimber, Marina Davoli. Cochrane Database Syst Rev 2009
851
15

Emerging adult age status predicts poor buprenorphine treatment retention.
Zev Schuman-Olivier, Roger D Weiss, Bettina B Hoeppner, Jacob Borodovsky, Mark J Albanese. J Subst Abuse Treat 2014
74
20

Medication-Assisted Treatment for Adolescents in Specialty Treatment for Opioid Use Disorder.
Kenneth A Feder, Noa Krawczyk, Brendan Saloner. J Adolesc Health 2017
43
34

Effectiveness of Injectable Extended-Release Naltrexone vs Daily Buprenorphine-Naloxone for Opioid Dependence: A Randomized Clinical Noninferiority Trial.
Lars Tanum, Kristin Klemmetsby Solli, Zill-E-Huma Latif, Jurate Šaltyte Benth, Arild Opheim, Kamni Sharma-Haase, Peter Krajci, Nikolaj Kunøe. JAMA Psychiatry 2017
142
14

Buprenorphine Treatment for Adolescents and Young Adults With Opioid Use Disorders: A Narrative Review.
Jacob T Borodovsky, Sharon Levy, Marc Fishman, Lisa A Marsch. J Addict Med 2018
25
56

Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
Evgeny Krupitsky, Edward V Nunes, Walter Ling, Ari Illeperuma, David R Gastfriend, Bernard L Silverman. Lancet 2011
342
13

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.
Joshua D Lee, Peter D Friedmann, Timothy W Kinlock, Edward V Nunes, Tamara Y Boney, Randall A Hoskinson, Donna Wilson, Ryan McDonald, John Rotrosen, Marc N Gourevitch,[...]. N Engl J Med 2016
190
13

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.
Paul J Fudala, T Peter Bridge, Susan Herbert, William O Williford, C Nora Chiang, Karen Jones, Joseph Collins, Dennis Raisch, Paul Casadonte, R Jeffrey Goldsmith,[...]. N Engl J Med 2003
372
13

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.
David A Fiellin, Michael V Pantalon, Marek C Chawarski, Brent A Moore, Lynn E Sullivan, Patrick G O'Connor, Richard S Schottenfeld. N Engl J Med 2006
240
10

Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.
David A Fiellin, Richard S Schottenfeld, Christopher J Cutter, Brent A Moore, Declan T Barry, Patrick G O'Connor. JAMA Intern Med 2014
117
10

Substance Use Screening, Brief Intervention, and Referral to Treatment.
Sharon J L Levy, Janet F Williams. Pediatrics 2016
143
10

Maintenance treatments for opiate -dependent adolescents.
Silvia Minozzi, Laura Amato, Cristina Bellisario, Marina Davoli. Cochrane Database Syst Rev 2014
27
37

Treatment utilization among persons with opioid use disorder in the United States.
Li-Tzy Wu, He Zhu, Marvin S Swartz. Drug Alcohol Depend 2016
197
10

Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial.
Yih-Ing Hser, Elizabeth Evans, David Huang, Robert Weiss, Andrew Saxon, Kathleen M Carroll, George Woody, David Liu, Paul Wakim, Abigail G Matthews,[...]. Addiction 2016
113
10

US National Trends in Pediatric Deaths From Prescription and Illicit Opioids, 1999-2016.
Julie R Gaither, Veronika Shabanova, John M Leventhal. JAMA Netw Open 2018
163
10

Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study.
Marc R Larochelle, Dana Bernson, Thomas Land, Thomas J Stopka, Na Wang, Ziming Xuan, Sarah M Bagley, Jane M Liebschutz, Alexander Y Walley. Ann Intern Med 2018
448
10


Buprenorphine tapering schedule and illicit opioid use.
Walter Ling, Maureen Hillhouse, Catherine Domier, Geetha Doraimani, Jeremy Hunter, Christie Thomas, Jessica Jenkins, Albert Hasson, Jeffrey Annon, Andrew Saxon,[...]. Addiction 2009
84
10

Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.
James Bell, Lieu Trinh, Bethany Butler, Deborah Randall, George Rubin. Addiction 2009
102
9

Opioid agonist treatment for pharmaceutical opioid dependent people.
Suzanne Nielsen, Briony Larance, Louisa Degenhardt, Linda Gowing, Chyanne Kehler, Nicholas Lintzeris. Cochrane Database Syst Rev 2016
160
9


Receipt of Addiction Treatment After Opioid Overdose Among Medicaid-Enrolled Adolescents and Young Adults.
Rachel H Alinsky, Bonnie T Zima, Jonathan Rodean, Pamela A Matson, Marc R Larochelle, Hoover Adger, Sarah M Bagley, Scott E Hadland. JAMA Pediatr 2020
42
21

Predictors of abstinence: National Institute of Drug Abuse multisite buprenorphine/naloxone treatment trial in opioid-dependent youth.
Geetha A Subramaniam, Diane Warden, Abu Minhajuddin, Marc J Fishman, Maxine L Stitzer, Bryon Adinoff, Madhukar Trivedi, Roger Weiss, Jennifer Potter, Sabrina A Poole,[...]. J Am Acad Child Adolesc Psychiatry 2011
40
20



Geographic and specialty distribution of US physicians trained to treat opioid use disorder.
Roger A Rosenblatt, C Holly A Andrilla, Mary Catlin, Eric H Larson. Ann Fam Med 2015
244
8

How the paediatric workforce can address the opioid crisis.
Scott E Hadland, Evan Wood, Sharon Levy. Lancet 2016
18
44

Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial.
Gail D'Onofrio, Patrick G O'Connor, Michael V Pantalon, Marek C Chawarski, Susan H Busch, Patricia H Owens, Steven L Bernstein, David A Fiellin. JAMA 2015
464
8

Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.
Lawrence Scholl, Puja Seth, Mbabazi Kariisa, Nana Wilson, Grant Baldwin. MMWR Morb Mortal Wkly Rep 2018
8

Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Barbara R Haight, Susan M Learned, Celine M Laffont, Paul J Fudala, Yue Zhao, Amanda S Garofalo, Mark K Greenwald, Vijay R Nadipelli, Walter Ling, Christian Heidbreder. Lancet 2019
112
8


Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine/naloxone.
Richard N Rosenthal, Walter Ling, Paul Casadonte, Frank Vocci, Genie L Bailey, Kyle Kampman, Ashwin Patkar, Steven Chavoustie, Christine Blasey, Stacey Sigmon,[...]. Addiction 2013
65
10

Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.
Walter Ling, Paul Casadonte, George Bigelow, Kyle M Kampman, Ashwin Patkar, Genie L Bailey, Richard N Rosenthal, Katherine L Beebe. JAMA 2010
99
7


National Trends in Hospitalizations for Opioid Poisonings Among Children and Adolescents, 1997 to 2012.
Julie R Gaither, John M Leventhal, Sheryl A Ryan, Deepa R Camenga. JAMA Pediatr 2016
193
7

Pharmacologically assisted treatment of opioid-dependent youth.
Anna Pecoraro, Marc Fishman, Michelle Ma, Gvantsa Piralishvili, George E Woody. Paediatr Drugs 2013
15
46

Neurobiology of addiction: a neurocircuitry analysis.
George F Koob, Nora D Volkow. Lancet Psychiatry 2016
7

Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniors.
Joseph J Palamar, Jenni A Shearston, Eric W Dawson, Pedro Mateu-Gelabert, Danielle C Ompad. Drug Alcohol Depend 2016
72
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.